Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H25NO6 |
Molecular Weight | 399.437 |
Optical Activity | ( - ) |
Additional Stereochemistry | Yes |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
Stereo Comments | M-helix |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C(OC)=C1OC)C3=CC=C(OC)C(=O)C=C3[C@H](CC2)NC(C)=O
InChI
InChIKey=IAKHMKGGTNLKSZ-INIZCTEOSA-N
InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1
Molecular Formula | C22H25NO6 |
Molecular Weight | 399.437 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:19:06 UTC 2023
by
admin
on
Fri Dec 15 17:19:06 UTC 2023
|
Record UNII |
SML2Y3J35T
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QM04AC01
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
11085
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
245707
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
245807
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
||
|
NCI_THESAURUS |
C67421
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
||
|
WHO-ATC |
M04AC01
Created by
admin on Fri Dec 15 17:19:06 UTC 2023 , Edited by admin on Fri Dec 15 17:19:06 UTC 2023
|
||
|
LIVERTOX |
NBK548068
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
200-598-5
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
3044
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
COLCHICINE
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | Description: Pale yellow to pale greenish yellow crystals, amorphous scales or a powder; odourless or almost odourless.Solubility: Soluble in water; freely soluble in ethanol (~750 g/l) TS; slightly soluble in ether R.Category: Antigout drug.Storage: Colchicine should be kept in a tightly closed container, protected from light.Additional information: Colchicine is an alkaloid obtained from Colchicum autumnale L. (Fam. Liliaceae). It darkens on exposureto light. CAUTION: Colchicine is extremely poisonous and must be handled with care. | ||
|
Colchicine
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
m3725
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | Merck Index | ||
|
SML2Y3J35T
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
D003078
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
CHEMBL107
Created by
admin on Fri Dec 15 17:19:06 UTC 2023 , Edited by admin on Fri Dec 15 17:19:06 UTC 2023
|
PRIMARY | |||
|
6167
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
N0000000239
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | P-Glycoprotein Interactions [MoA] | ||
|
N0000182141
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | Cytochrome P450 3A4 Inhibitors [MoA] | ||
|
SML2Y3J35T
Created by
admin on Fri Dec 15 17:19:06 UTC 2023 , Edited by admin on Fri Dec 15 17:19:06 UTC 2023
|
PRIMARY | |||
|
64-86-8
Created by
admin on Fri Dec 15 17:19:06 UTC 2023 , Edited by admin on Fri Dec 15 17:19:06 UTC 2023
|
PRIMARY | |||
|
C385
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
27882
Created by
admin on Fri Dec 15 17:19:06 UTC 2023 , Edited by admin on Fri Dec 15 17:19:06 UTC 2023
|
PRIMARY | |||
|
DTXSID5024845
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
726
Created by
admin on Fri Dec 15 17:19:06 UTC 2023 , Edited by admin on Fri Dec 15 17:19:06 UTC 2023
|
PRIMARY | |||
|
2367
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
757
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
1146006
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
2683
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | RxNorm | ||
|
COLCHICINE
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
SUB01420MIG
Created by
admin on Fri Dec 15 17:19:06 UTC 2023 , Edited by admin on Fri Dec 15 17:19:06 UTC 2023
|
PRIMARY | |||
|
100000090556
Created by
admin on Fri Dec 15 17:19:07 UTC 2023 , Edited by admin on Fri Dec 15 17:19:07 UTC 2023
|
PRIMARY | |||
|
DB01394
Created by
admin on Fri Dec 15 17:19:06 UTC 2023 , Edited by admin on Fri Dec 15 17:19:06 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TARGET->INHIBITOR OF AGGREGATION |
DESTABILIZES TUBULIN POLYMERS
|
||
|
DERIVATIVE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
APICAL
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE LESS ACTIVE -> PARENT |
URINE
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||